| lrpowerequiv {lrstat} | R Documentation |
Power for equivalence in hazard ratio
Description
Obtains the power for equivalence in hazard ratio.
Usage
lrpowerequiv(
kMax = 1L,
informationRates = NA_real_,
criticalValues = NA_real_,
alpha = 0.05,
typeAlphaSpending = "sfOF",
parameterAlphaSpending = NA_real_,
userAlphaSpending = NA_real_,
hazardRatioLower = NA_real_,
hazardRatioUpper = NA_real_,
allocationRatioPlanned = 1,
accrualTime = 0L,
accrualIntensity = NA_real_,
piecewiseSurvivalTime = 0L,
stratumFraction = 1L,
lambda1 = NA_real_,
lambda2 = NA_real_,
gamma1 = 0L,
gamma2 = 0L,
accrualDuration = NA_real_,
followupTime = NA_real_,
fixedFollowup = 0L,
typeOfComputation = "direct",
spendingTime = NA_real_,
studyDuration = NA_real_
)
Arguments
kMax |
The maximum number of stages. |
informationRates |
The information rates.
Defaults to |
criticalValues |
Upper boundaries on the z-test statistic scale for stopping for efficacy. |
alpha |
The significance level for each of the two one-sided tests. Defaults to 0.05. |
typeAlphaSpending |
The type of alpha spending. One of the following: "OF" for O'Brien-Fleming boundaries, "P" for Pocock boundaries, "WT" for Wang & Tsiatis boundaries, "sfOF" for O'Brien-Fleming type spending function, "sfP" for Pocock type spending function, "sfKD" for Kim & DeMets spending function, "sfHSD" for Hwang, Shi & DeCani spending function, "user" for user defined spending, and "none" for no early efficacy stopping. Defaults to "sfOF". |
parameterAlphaSpending |
The parameter value for the alpha spending. Corresponds to Delta for "WT", rho for "sfKD", and gamma for "sfHSD". |
userAlphaSpending |
The user defined alpha spending. Cumulative alpha spent up to each stage. |
hazardRatioLower |
The lower equivalence limit of hazard ratio. |
hazardRatioUpper |
The upper equivalence limit of hazard ratio. |
allocationRatioPlanned |
Allocation ratio for the active treatment versus control. Defaults to 1 for equal randomization. |
accrualTime |
A vector that specifies the starting time of
piecewise Poisson enrollment time intervals. Must start with 0, e.g.,
|
accrualIntensity |
A vector of accrual intensities. One for each accrual time interval. |
piecewiseSurvivalTime |
A vector that specifies the starting time of
piecewise exponential survival time intervals. Must start with 0, e.g.,
|
stratumFraction |
A vector of stratum fractions that sum to 1. Defaults to 1 for no stratification. |
lambda1 |
A vector of hazard rates for the event in each analysis time interval by stratum for the active treatment group. |
lambda2 |
A vector of hazard rates for the event in each analysis time interval by stratum for the control group. |
gamma1 |
The hazard rate for exponential dropout, a vector of hazard rates for piecewise exponential dropout applicable for all strata, or a vector of hazard rates for dropout in each analysis time interval by stratum for the active treatment group. |
gamma2 |
The hazard rate for exponential dropout, a vector of hazard rates for piecewise exponential dropout applicable for all strata, or a vector of hazard rates for dropout in each analysis time interval by stratum for the control group. |
accrualDuration |
Duration of the enrollment period. |
followupTime |
Follow-up time for the last enrolled subject. |
fixedFollowup |
Whether a fixed follow-up design is used. Defaults to 0 for variable follow-up. |
typeOfComputation |
The type of computation, either "direct" for the direct approximation method, or "schoenfeld" for the Schoenfeld method. Defaults to "direct". Can use "Schoenfeld" under proportional hazards and conventional log-rank test. |
spendingTime |
A vector of length |
studyDuration |
Study duration for fixed follow-up design.
Defaults to missing, which is to be replaced with the sum of
|
Value
An S3 class lrpowerequiv object with 4 components:
-
overallResults: A data frame containing the following variables:-
overallReject: The overall rejection probability. -
alpha: The overall significance level. -
attainedAlphaH10: The attained significance level under H10. -
attainedAlphaH20: The attained significance level under H20. -
numberOfEvents: The total number of events. -
numberOfDropouts: The total number of dropouts. -
numbeOfSubjects: The total number of subjects. -
studyDuration: The total study duration. -
information: The maximum information. -
expectedNumberOfEvents: The expected number of events. -
expectedNumberOfDropouts: The expected number of dropouts. -
expectedNumberOfSubjects: The expected number of subjects. -
expectedStudyDuration: The expected study duration. -
expectedInformation: The expected information. -
kMax: The number of stages. -
hazardRatioLower: The lower equivalence limit of hazard ratio. -
hazardRatioUpper: The upper equivalence limit of hazard ratio. -
accrualDuration: The accrual duration. -
followupTime: The follow-up time. -
fixedFollowup: Whether a fixed follow-up design is used.
-
-
byStageResults: A data frame containing the following variables:-
informationRates: The information rates. -
efficacyBounds: The efficacy boundaries on the Z-scale for each of the two one-sided tests. -
rejectPerStage: The probability for efficacy stopping. -
cumulativeRejection: The cumulative probability for efficacy stopping. -
cumulativeAlphaSpent: The cumulative alpha for each of the two one-sided tests. -
cumulativeAttainedAlphaH10: The cumulative alpha attained underH10. -
cumulativeAttainedAlphaH20: The cumulative alpha attained underH20. -
numberOfEvents: The number of events. -
numberOfDropouts: The number of dropouts. -
numberOfSubjects: The number of subjects. -
analysisTime: The average time since trial start. -
efficacyHRLower: The efficacy boundaries on the hazard ratio scale for the one-sided null hypothesis at the lower equivalence limit. -
efficacyHRUpper: The efficacy boundaries on the hazard ratio scale for the one-sided null hypothesis at the upper equivalence limit. -
efficacyP: The efficacy bounds on the p-value scale for each of the two one-sided tests. -
information: The cumulative information. -
HR: The average hazard ratio.
-
-
settings: A list containing the following input parameters:typeAlphaSpending,parameterAlphaSpending,userAlphaSpending,allocationRatioPlanned,accrualTime,accuralIntensity,piecewiseSurvivalTime,stratumFraction,lambda1,lambda2,gamma1,gamma2,typeOfComputation, andspendingTime. -
byTreatmentCounts: A list containing the following counts by treatment group:-
numberOfEvents1: The number of events by stage for the treatment group. -
numberOfDropouts1: The number of dropouts by stage for the treatment group. -
numberOfSubjects1: The number of subjects by stage for the treatment group. -
numberOfEvents2: The number of events by stage for the control group. -
numberOfDropouts2: The number of dropouts by stage for the control group. -
numberOfSubjects2: The number of subjects by stage for the control group. -
expectedNumberOfEvents1: The expected number of events for the treatment group. -
expectedNumberOfDropouts1: The expected number of dropouts for the treatment group. -
expectedNumberOfSubjects1: The expected number of subjects for the treatment group. -
expectedNumberOfEvents2: The expected number of events for control group. -
expectedNumberOfDropouts2: The expected number of dropouts for the control group. -
expectedNumberOfSubjects2: The expected number of subjects for the control group.
-
Author(s)
Kaifeng Lu, kaifenglu@gmail.com
See Also
Examples
lrpowerequiv(kMax = 2, informationRates = c(0.5, 1),
alpha = 0.05, typeAlphaSpending = "sfOF",
hazardRatioLower = 0.71, hazardRatioUpper = 1.4,
allocationRatioPlanned = 1, accrualTime = seq(0, 8),
accrualIntensity = 100/9*seq(1, 9),
piecewiseSurvivalTime = c(0, 6),
stratumFraction = c(0.2, 0.8),
lambda1 = c(0.0533, 0.0533, 1.5*0.0533, 1.5*0.0533),
lambda2 = c(0.0533, 0.0533, 1.5*0.0533, 1.5*0.0533),
gamma1 = -log(1-0.05)/12,
gamma2 = -log(1-0.05)/12, accrualDuration = 22,
followupTime = 18, fixedFollowup = FALSE)